81 related articles for article (PubMed ID: 8101765)
1. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein.
Krishnamachary N; Center MS
Cancer Res; 1993 Aug; 53(16):3658-61. PubMed ID: 8101765
[TBL] [Abstract][Full Text] [Related]
2. Expression and phylogeny of multidrug resistance protein 2 and 4 in African white backed vulture
Nethathe B; Abera A; Naidoo V
PeerJ; 2020; 8():e10422. PubMed ID: 33344079
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy.
Theodossiou TA; Ali M; Grigalavicius M; Grallert B; Dillard P; Schink KO; Olsen CE; Wälchli S; Inderberg EM; Kubin A; Peng Q; Berg K
NPJ Breast Cancer; 2019; 5():13. PubMed ID: 30993194
[TBL] [Abstract][Full Text] [Related]
4. Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference.
Xie N; Mou L; Yuan J; Liu W; Deng T; Li Z; Jing Y; Hu Z
PLoS One; 2014; 9(7):e103463. PubMed ID: 25076217
[TBL] [Abstract][Full Text] [Related]
5. Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle.
Kumar R; Kulkarni A; Nabulsi J; Nagesha DK; Cormack R; Makrigiorgos MG; Sridhar S
Drug Deliv Transl Res; 2013 Aug; 3(4):299-308. PubMed ID: 23914343
[TBL] [Abstract][Full Text] [Related]
6. Photochemically generated elemental selenium forms conjugates with serum proteins that are preferentially cytotoxic to leukemia and selected solid tumor cells.
Daziano JP; Günther WH; Krieg M; Tsujino I; Miyagi K; Anderson GS; Sampson RW; Ostrowski MD; Muir SA; Bula RJ; Sieber F
Photochem Photobiol; 2012; 88(2):448-60. PubMed ID: 22211823
[TBL] [Abstract][Full Text] [Related]
7. A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.
Ahmed AA; Goldsmith J; Fokt I; Le XF; Krzysko KA; Lesyng B; Bast RC; Priebe W
Cancer Chemother Pharmacol; 2011 Oct; 68(4):1033-44. PubMed ID: 21340606
[TBL] [Abstract][Full Text] [Related]
8. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.
Pal D; Kwatra D; Minocha M; Paturi DK; Budda B; Mitra AK
Life Sci; 2011 May; 88(21-22):959-71. PubMed ID: 20932495
[TBL] [Abstract][Full Text] [Related]
9. Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11).
Zunino SJ; Storms DH; Ducore JM
Cancer Lett; 2010 Oct; 296(1):49-54. PubMed ID: 20381955
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis of the putative nucleotide-binding domains of the multidrug resistance associated protein (MRP). Analysis of the effect of these mutations on MRP mediated drug resistance and transport.
Center MS; Zhu Q; Sun H
Cytotechnology; 1998 Sep; 27(1-3):61-9. PubMed ID: 19002783
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.
Kim D; Lee ES; Oh KT; Gao ZG; Bae YH
Small; 2008 Nov; 4(11):2043-50. PubMed ID: 18949788
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.
Łubgan D; Jóźwiak Z; Grabenbauer GG; Distel LV
Cell Mol Biol Lett; 2009; 14(1):113-27. PubMed ID: 18850074
[TBL] [Abstract][Full Text] [Related]
13. MDR- and CYP3A4-mediated drug-drug interactions.
Pal D; Mitra AK
J Neuroimmune Pharmacol; 2006 Sep; 1(3):323-39. PubMed ID: 18040809
[TBL] [Abstract][Full Text] [Related]
14. The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.
Kostrzewa-Nowak D; Paine MJ; Wolf CR; Tarasiuk J
Br J Cancer; 2005 Jul; 93(1):89-97. PubMed ID: 15942634
[TBL] [Abstract][Full Text] [Related]
15. Gamma-tocopheryl quinone stimulates apoptosis in drug-sensitive and multidrug-resistant cancer cells.
Jones KH; Liu JJ; Roehm JS; Eckel JJ; Eckel TT; Stickrath CR; Triola CA; Jiang Z; Bartoli GM; Cornwell DG
Lipids; 2002 Feb; 37(2):173-84. PubMed ID: 11908909
[TBL] [Abstract][Full Text] [Related]
16. MRP subfamily transporters and resistance to anticancer agents.
Kruh GD; Zeng H; Rea PA; Liu G; Chen ZS; Lee K; Belinsky MG
J Bioenerg Biomembr; 2001 Dec; 33(6):493-501. PubMed ID: 11804191
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance-associated protein (MRP) in human gliomas.
Mohri M; Nitta H; Yamashita J
J Neurooncol; 2000 Sep; 49(2):105-15. PubMed ID: 11206006
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.
Minko T; Kopecková P; Kopecek J
Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921
[TBL] [Abstract][Full Text] [Related]
19. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.
Alexander D; Yamamoto T; Kato S; Kasai S
Surg Today; 1999; 29(5):401-6. PubMed ID: 10333409
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione.
Barnouin K; Leier I; Jedlitschky G; Pourtier-Manzanedo A; König J; Lehmann WD; Keppler D
Br J Cancer; 1998; 77(2):201-9. PubMed ID: 9460989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
